FDA Drug Application (020725) for CREON by ABBVIE

Back to FDA Applications sponsored by ABBVIE

Application Number020725
Product Number001
FormCAPSULE, DELAYED RELEASE;ORAL
Dosage30,000USP UNITS;6,000USP UNITS;19,000USP UNITS
Product Market Status Prescription
Therapeutic Equivalence Evaluation Code
Reference Drug
Drug NameCREON
Active IngredientPANCRELIPASE (AMYLASE;LIPASE;PROTEASE)



Back to FDA Applications sponsored by ABBVIE

Problems, Comments, Suggestions? Click here to contact Greg Thatcher

Please read my Disclaimer





Copyright (c) 2013 Thatcher Development Software, LLC. All rights reserved. No claim to original U.S. Gov't works.